NCT00998062View on ClinicalTrials.gov

Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population. Database Analysis of Previous Studies Performed in Spain

CompletedOBSERVATIONAL
Enrollment

30,181

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
DyslipaemiaAtherosclerosis RiskIncreased hsCRPInflammatory and Oxidative Status in the Spanish Population
Trial Locations (11)

Unknown

Research Site, Andalucia

Research Site, Canarias

Research Site, Castilla Y Leon

Research Site, Talavero

Research Site, Girona

Research Site, Hospitalet

Research Site, Badajoz

Research Site, Madrid

Research Site, Mallorca

Research Site, Murcia

Research Site, Navarra

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY